Extragenital manifestations of Neisseria gonorrhoeae

Current Infectious Disease Reports

Volumn 8, Issue 2, 2006, Pages 132-138

  Spencer, Steven E ^b   Bash, Margaret C ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL VACCINE; CEFIXIME; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MICROBICIDE; NONOXINOL 9; OFLOXACIN; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SILVER NITRATE; SPECTINOMYCIN; SPERMICIDAL AGENT; TETRACYCLINE;

BACTERIAL ENDOCARDITIS; BACTERIAL MENINGITIS; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHEMOSIS; CHORIOAMNIONITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONDOM; CONJUNCTIVITIS; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; GENITAL SYSTEM DISEASE; GONOCOCCAL ARTHRITIS; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAUTERINE INFECTION; NEISSERIA GONORRHOEAE; NEWBORN INFECTION; NEWBORN OPHTHALMIA; NEWBORN SEPSIS; NONHUMAN; PATHOGENESIS; PHARYNX DISEASE; POPULATION RESEARCH; RECTUM DISEASE; REVIEW; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEPTIC ABORTION; SEXUALLY TRANSMITTED DISEASE; SKIN ABSCESS; TISSUE SPECIFICITY; UROGENITAL TRACT INFECTION;

EID: 33645294933     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0009-5     Document Type: Review

References (51)

1. Centers for Disease Control and Prevention: Sexually Transmitted Disease Surveillance, 2003. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.
2. Sparling PF, Handsfield HH: Neisseria gonorrhoeae. In Principles and Practice of Infectious Diseases, edn 5. Edited by Mandell GL, Bennett JE. Philadelphia: Churchill Livingstone; 2000:2242-2258.
3. Woods CR: Gonococcal infections in neonates and young children. Semin Pediatr Infect Dis 2005, 16:258-270.
4. Boulton IC, Gray-Owen SD: Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol 2002, 3:229-236.
5. Gorby GL, Ehrhardt AF, Apicella MA, Elkins C: Invasion of human fallopian tube epithelium by Escherichia coli expressing combinations of a gonococcal porin, opacity-associated protein, and chimeric lipo-oligosaccharide. J Infect Dis 2001, 184:460-472.
6. Ngampasutadol J, Ram S, Blom AM, et al.: Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc Natl Acad Sci U S A 2005, 102:17142-17147.
7. Edwards JL, Apicella MA: The role of lipooligosaccharide in Neisseria gonorrhoeae pathogenesis of cervical epithelia: lipid A serves as a C3 acceptor molecule. Cell Microbiol 2002, 4:585-598.
8. American Social Health Association: Sexually transmitted diseases in America: How many cases and at what cost? Research Triangle Park, NC: American Social Health Association; 1998.
9. Thomas JC, Schoenbach VJ, Weiner DH, et al.: Rural gonorrhea in the southeastern United States: a neglected epidemic? Am J Epidemiol 1996, 143:269-277.
10. Oppenheimer EH, Winn KJ: Fetal gonorrhea with deep tissue infection occurring in utero. Pediatrics 1982, 69:74-76.
11. Pantanowitz L, Hodkinson J, Zeelie R, Jones N: Gonococcal endocarditis after a threatened abortion. A case report. J Reprod Med 1998, 43:1043-1045.
12. Nickerson CW: Gonorrhea amnionitis. Obstet Gynecol 1973, 42:815-817.
13. Stoll BJ, Kanto WP Jr, Glass RI, Pushkin J: Treated maternal gonorrhea without adverse effect on outcome of pregnancy. South Med J 1982, 75:1236-1238.
14. Friendly DS: Gonorrheal ophthalmia. Trans Am Acad Ophthalmol Otolaryngol 1970, 74:975-983.
15. Gutman LT: Gonococcal infections. In Infectious Diseases of the Fetus and Newborn Infant, edn 5. Edited by Remington JS, Klein JO. Philadelphia: W.B. Saunders Co.; 2001:1199-1215.
16. Babl FE, Ram S, Barnett ED, et al.: Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis. Pediatr Infect Dis J 2000, 19:346-349.
17. Woods C: Gonorrhea. In Textbook of Pediatric Infectious Diseases, edn 5. Edited by Feigin RD, Cherry CJ. Philadelphia: W.B. Saunders, Co.; 2003:1280-1304.
18. Committee on Infectious Diseases, American Academy of Pediatrics: Gonococcal infections. In Red Book: 2003 Report of the Committee on Infectious Diseases, edn 26. Edited by Pickering LK, Baker CJ, Overturf GD, Prober CG. Elk Grove Village, IL: American Academy of Pediatrics; 2003:285-291.
19. Varady E, Nsanze H, Slattery T: Gonococcal scalp abscess in a neonate delivered by caesarean section. Sex Transm Infect 1998, 74:451.
20. Glaser S, Boxerbaum B, Kennell JH: Gonococcal arthritis in the newborn. Report of a case and review of the literature. Am J Dis Child 1966, 112:185-188.
21. Rice PA: Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005, 19:853-861.
22. O'Brien JP, Goldenberg DL, Rice PA: Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983, 62:395-406.
23. Brunham RC, Plummer F, Slaney L, et al.: Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae. J Infect Dis 1985, 152:339-343.
24. Bash MC, Zhu P, Gulati S, et al.: por Variable-region typing by DNA probe hybridization is broadly applicable to epidemiologic studies of Neisseria gonorrhoeae. J Clin Microbiol 2005, 43:1522-1530.
25. Ram S, Mackinnon FG, Gulati S, et al.: The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol 1999, 36:915-928.
26. Ghosh SK, Zhao J, Philogene MC, et al.: Pathogenic consequences of Neisseria gonorrhoeae pilin glycan variation. Microbes Infect 2004, 6:693-701.
27. Dillard JP, Seifert HS: A variable genetic island specific for Neisseria gonorrhoeae is involved in providing DNA for natural transformation and is found more often in disseminated infection isolates. Mol Microbiol 2001, 41:263-277.
28. Mehrany K, Kist JM, O'Connor WJ, DiCaudo DJ: Disseminated gonococcemia. Int J Dermatol 2003, 42:208-209.
29. Russ S, Wrenn K: Images in clinical medicine. Disseminated gonococcal infection. N Engl J Med 2005, 352:e15.
30. Shetty A, Ribeiro D, Evans A, Linnane S: Gonococcal endocarditis: a rare complication of a common disease. J Clin Pathol 2004, 57:780-781.
31. Jackman JD Jr, Glamann DB: Gonococcal endocarditis: twenty-five year experience. Am J Med Sci 1991, 301:221-230.
32. Sobel JL, Maisel AS, Tarazi R, Blanchard DG: Gonococcal endocarditis: assessment by transesophageal echocardiography. J Am Soc Echocardiogr 1997, 10:367-370.
33. McMillan A, Young H, Moyes A: Rectal gonorrhoea in homosexual men: source of infection. Int J STD AIDS 2000, 11:284-287.
34. Whiley DM, Buda PP, Freeman K, et al.: A real-time PCR assay for the detection of Neisseria gonorrhoeae in genital and extragenital specimens. Diagn Microbiol Infect Dis 2005, 52:1-5.
35. Young H, Manavi K, McMillan A: Evaluation of ligase chain reaction for the non-cultural detection of rectal and pharyngeal gonorrhoea in men who have sex with men. Sex Transm Infect 2003, 79:484-486.
36. Gaydos CA: Nucleic acid amplification tests for gonorrhea and chlamydia: practice and applications. Infect Dis Clin North Am 2005, 19:367-386, ix.
37. Palmer HM, Mallinson H, Wood RL, Herring AJ: Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae. J Clin Microbiol 2003, 41:835-837.
38. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men - United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR Morb Mortal Wkly Rep 2004, 53:335-338.
39. Manavi K, Young H, McMillan A: The outcome of oropharyngeal gonorrhoea treatment with different regimens. Int J STD AIDS 2005, 16:68-70.
40. Palusci VJ, Reeves MJ: Testing for genital gonorrhea infections in prepubertal girls with suspected sexual abuse. Pediatr Infect Dis J 2003, 22:618-623.
41. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services: Scientific evidence on condom effectiveness for sexually transmitted disease prevention. 2000. Bethesda, MD: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; 2001.
42. Zenilman JM, Deal CD: Gonorrhea: epidemiology, control and prevention. In Sexually Transmitted Disease: Vaccines, Prevention and Control. Edited by Stanberry LR, Bernstein BD. San Diego: Academic Press; 2000:369-386.
43. Price GA, Hobbs MM, Cornelissen CN: Immunogenicity of gonococcal transferrin binding proteins during natural infections. Infect Immun 2004, 72:277-283.
44. Stanberry LR, Rosenthal SL: Progress in vaccines for sexually transmitted diseases. Infect Dis Clin North Am 2005, 19:477-490.
45. Schmidt KA, Schneider H, Lindstrom JA, et al.: Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex Transm Dis 2001, 28:555-564.
46. Jerse AE: Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun 1999, 67:5699-5708.
47. Plante M, Jerse A, Hamel J, et al.: Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae. J Infect Dis 2000, 182:848-855.
48. Roddy RE, Cordero M, Cordero C, Fortney JA: A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993, 4:165-170.
49. Hooton TM, Scholes D, Hughes JP, et al.: A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996, 335:468-74.
50. Spencer SE, Valentin-Bon IE, Whaley K, Jerse AE: Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. J Infect Dis 2004, 189:410-419.
51. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002, 51(RR-6):1-78. Available at http://www.cdc.gov/STD/treatment/.